Eight years of real-world evidence on TARE: Lessons learned from CIRT and CIRT-FR
Join us for this CIRSE webinar, which marks the conclusion of eight years of data collection from the CIRT and CIRT-FR studies on transarterial radioembolization (TARE), as we share key findings with the wider IR community. With nearly 10,000 CIRSE members, our goal is to extend the impact of these results beyond scientific publications and congress presentations, making them more accessible and relevant to everyday clinical practice across Europe.
As the dissemination phase of these studies ends, this webinar will highlight major findings, explore new research directions, and encourage broader member engagement through interactive discussions and live voting. Key topics include the clinical application of TARE in real-world settings, its role in downstaging strategies, the potential of underexplored predictors of treatment effectiveness, and TARE’s application in non-colorectal liver metastatic tumours. This is an opportunity to reflect, engage, and shape future research within the CIRSE community.
Learning objectives
- To highlight the value of real-world data collection, as well as the contributions of CIRT and CIRT-FR to current evidence
- To discuss contributions to regulatory and reimbursement agencies
- To explore other research questions beyond the initial endpoints
- To raise new questions and discuss future perspectives
Programme
Introduction by the moderators
Highlight the value of real-world data collection as well as CIRT and CIRT-FR contribution to current evidence: Main results
Contribution to regulatory and reimbursement agencies
Contribution to research questions beyond the initial endpoints
Open questions and future perspectives
Take home points by moderator
Faculty
Moderators


Speakers
Speakers will be announced soon.
Join free of charge!
Access to this webinar is available free of charge to all interested parties. All you need is your CIRSE login details. Don’t have a CIRSE account yet? Not to worry! It only takes two minutes to set up a new account which will enable you to register.